姓名：曹彬 性别：男 职称：主任医师、教授 招生院所：中日友好医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：内科学（呼吸系病）(博) 内科学（呼吸系病）(硕) 研究方向名称：急性呼吸道感染和新发呼吸道传染病 电子信箱：caobin_ben@163.com


社会任职
1. International Society for Influenza and other Respiratory Virus Diseases (ISIRV) 学会委员
2. 中华医学会呼吸病学分会感染学组副组长
3. 中华医学会北京分会感染专业委员会常委兼秘书
4. 国家卫生计生委人感染H7N9禽流感临床专家组成员
5. 北京医师协会内科医师分会理事
6. 北京医师协会感染医师分会常务理事
7. 中国医师协会感染科医师分会第二届委员会委员
8. 卫生部药物合理应用委员会抗生素合理应用专家委员会委员
9. 卫生部甲型H1N1临床专家组成员
10. Clinical Respiratory Journal (CRJ)副主编
11. 中华医学会呼吸病学分会副主任委员
12. 北京医学会感染病学分会第八届委员会常务委员
13. 中国医疗保健国际交流促进会临床微生物与感染分会副主任委员
14. 中华医学会呼吸病学分会第十届委员会感染学组副组长
15. 中华实验室和临床病毒学杂志 第六届编辑委员会副总编辑
16. 中国宋庆龄基金会呼吸疾病临床研究公益基金 科学专家委员会委员
17. 中华预防医学会流感预防控制工作委员会第一届委员会副主任
18. 英国医学杂志中文版第五届编辑委员会编辑委员
19. 清华大学医学院兼职教授
20. 北京化工大学兼职教授
21. 医学分子生物学国家重点实验室第四届学术委员会委员
22. 首都医科大学呼吸系感染临床诊疗与研究中心执行主任
23. 中国医学科学院呼吸病学研究院副院长
24. 中华医学会呼吸病学分会候任主任委员
个人简历
1. 199009-199207:山东大学生物系 学习
2. 199208-199607:山东医科大学临床医学(七年制) 学习
3. 199608-199807:中国协和医科大学(七转八年制) 学习
4. 199808-200206:北京协和医院内科 住院医师
5. 200207-200302:北京协和医院内科 总住院医师
6. 200303-200609:北京协和医院呼吸内科 主治医师
7. 200610-201505:首都医科大学附属北京朝阳医院 科室主任
8. 201506-:中日友好医院 副院长/科室主任
重要学术论文
1. Zhou F#, Yu T#, Du R#, Fan G#, Liu Y#, Liu Z#, Xiang J#, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H*, Cao B*..Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.. Lancet. 2020,395 (10229):1054-1062.SCI
2. Huang C#, Wang Y#, Li X#, Ren L#, Zhao J#, Hu Y#, Zhang L#, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J*, Cao B*. .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.. Lancet. 2020,395 (10223):497-506.SCI
3. Cao B#*, Wang Y#, Wen D#, Liu W#, Wang J#, Fan G#, Ruan L#, Song B#, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H , Shang L , Wang K , Li K , Zhou X , Dong X , Qu Z , Lu S , Hu X , Ruan S , Luo S , Wu J , Peng L , Cheng F , Pan L , Zou J , Ji.A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.. N Engl J Med. 2020,-:-.SCI
4. Gao C#, Wang Y#, Gu X#, Shen X, Zhou D, Zhou S, Huang JA, Cao B*, Guo Q*; for the Community-Acquired Pneumonia–China Network..Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus.. Crit Care Med. 2020,48(4):451-458.SCI
5. Duan S#,Gu X#,Fan G,Sun R,Wang Y,Yu D,Li H,Xiong Z,Lu B,Zhu G,Cao B*..Evaluation of a molecular point of care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: A randomized Clinical Trial.. Clin Microbiol and Infect. 2019,25(11):1415-1421.SCI
6. Zhou F#, Wang Y#, Liu Y#, Liu X#, Gu L#, Zhang X#, Pu Z#, Yang G#, Liu B#, Nie Q, Xue B, Feng J, Guo Q, Liu J, Fan H, Chen J, Zhang Y, Xu Z, Pang M, Chen Y, Nie X, Cai Z, Xu J, Peng K, Li X, Xiang P, Zhang Z, Jiang S, Su X, Zhang J, Li Y, Jin X, Jiang R, Dong J, Song Y, Zhou H, Wang C, Cao B*;.Disease severity and clinical outcomes of community acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicenter prospective registry study from CAP-China Network.. European Respiratory Journal . 2019,54(2):**.SCI
7. Wang Y#, Fan G#, Salam A, Horby P, Hayden FG, Chen C, Pan J, Zheng J, Lu B, Guo L, Wang C, Cao B*; CAP-China Network..Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.. J Infect Dis. 2019,-:-.SCI
8. Zou X#, Chang K, Wang Y, Li M, Zhang W, Wang C, Lu B, Xiong Z, Han J, Zhang Y, Zhao J, Cao B*; for CAP-China Network.Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A andinfluenza B in a prospective cohort from China. Int J Infect Dis. 2019,80:92-97.SCI
9. Wang J#, Cao B*..Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance. . Curr Opin Pulm Med. 2019,25 (2):158-164.SCI
10. Wang Y#, Fan G, Horby P, Hayden F, Li Q, Wu Q, Zou X, Li H, Zhan Q, Wang C, Cao B*; CAP-China Network. .Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale. Open Forum Infect Dis. 2019,6(3):ofz053.SCI
11. Shi Y#, Huang Y#, Zhang TT#, Cao B#, Wang H#, Zhuo C#, Ye F#, Su X#, Fan H#, Xu JF#, Zhang J#, Lai GX#, She DY#, Zhang XY, He B, He LX, Liu YN, Qu JM*. .Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition).. J Thorac Dis. 2019,11(6):2581-2616.SCI
12. Cao B#*, Huang Y#, She D-Y, Cheng Q-J, Fan H, Tian X-L, Xu J-F, Zhang J, Chen Y, Shen N, Wang H, Jiang M, Zhang X-Y, Shi Y, He B, He L-X, Liu Y-N, Qu J-M*. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018,12(4):1320-1360.SCI
13. Li H#, Bradley KC#, Long JS, Frise R, Ashcroft JW, Hartgroves LC, Shelton H, Makris S, Johansson C, Cao B*, Barclay WS*.Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.[J]. Plos Pathogens. 2018,14(1):e**.SCI
14. Chen L#, Zhou F, Li H, Xing X, Han X, Wang Y, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Uyeki TM, Wang C, Cao B*.Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open. 2018,8(2):e018709 .SCI
15. Zou X#, Guo Q#, Zhang W#, Chen H, Bai W, Lu B, Zhang W, Fan Y, Liu C, Wang Y, Zhou F, Cao B*.Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection. J Infect Dis. 2018,218(4):586-594.SCI
16. Zhou F#, Li H, Gu L, Liu M, Xue C, Cao B*, Wang C. Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients. Respir Med. 2018,134:86-91.SCI
17. Zhang Y#, Wang Q#, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, Li W, Zhang X, Liao K, Man S, Wang S, Wen H, Li B, Guo Z, Tian J, Pei F, Liu L, Zhang L, Zou C, Hu T, Cai J, Yang H, Huang J, Jia X, Huang W, Cao B*, Wang H*. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018,62(2):e01882-17.SCI
18. Cheng ZT# ; Yan YQ# ; Jing SP ; Li WG ; Chen WW ; Zhang J; Li M; Zhao S ; Cao N; Ou JX; Zhao SH; Wu XB*; Cao B*; Zhang QW* .Comparative Genomic Analysis of Re-emergent Human Adenovirus Type 55 Pathogens Associated With Adult Severe Community-Acquired Pneumonia Reveals Conserved Genomes and Capsid Proteins[J]. Frontiers in Microbiology. 2018,9:1180.SCI
19. Zhou F#, Gu L, Qu JX, Liu YM, Cao B*.Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China. Clin Respir J. 2018,12(2):425-432.SCI
20. Guo LP# ; Jiang Y ; Liu YM ; Cao B*.First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China[J]. The Clinical Respiratory Journal. 2018,12(11):2581-2589.SCI
21. Liu M#, Li H, Xue CX, Gu L, Qu JX, Yu XM, Wang YM, Liu YM, Cao B*.Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens. Clin Respir J. 2018,12(3):974-985.SCI
22. Zou XH# ; Fan YY ; Zhang W ; Lu BH ; Liu YM ; Cao B*.Metagenomics facilitated complete genome sequencing of adenovirus untyped by real-time PCR[J]. Journal of Infection. 2018,77(2):158-164.SCI
23. Huang L#, Zhang W#, Yang Y#, Wu W#, Lu W#, Xue H, Zhao H, Wu Y, Shang J, Cai L, Liu L, Liu D, Wang Y, Cao B*, Zhan Q*, Wang C.Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis. 2018,18(1):23.SCI
24. Han X#, Zhou F, Li H, Xing X, Chen L, Wang Y, Zhang C, Liu X, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Purdy JE, Cao B*. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia. BMC Infect Dis. 2018,18(1):192.SCI
25. Wang Y#, Guo Q#, Yan Z#, Zhou D#, Zhang W#, Zhou S#, Li Y-P#, Yuan J#, Uyeki TM#, Shen X#, Wu W#, Zhao H, Wu Y-F, Shang J, He Z, Yang Y, Zhao H, Hong Y, Zhang Z, Wu M, Wei T, Deng X, Deng Y, Cai L, Lu W, Shu H, Zhang L, Luo H, ing Zhou Y, Weng H, Song K, Yao L, Jiang M, Zhao B, Chi R, Guo B, Fu L, Y.Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection. J Infect Dis. 2018,217(11):1708-1717.SCI
26. Jia X#, Liu B#, Bao L#, Lv Q, Li F, Li H, An Y, Zhang X*, Cao B*, Wang C*.Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018,14(11):e**.SCI
27. Yu D#, Zhang G, Gao L, Xu W, Cao B*.High ratio of measles-specific IgG/IgM associated with nodular pneumonia in vaccinated individuals. Int J Infect Dis. 2018,76:38-44.SCI
28. Cao B#*, Qu J-X#, Yin Y-D#, Eldere J Van#.Overview of antimicrobial options for M ycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J. 2017,11(4):419-429.SCI
29. Li H#, Yang S, Gu L, Zhang Y, Yan X, Liang Z, Zhang W, Jia H, Chen W, Liu M, Yu K, Xue C, Hu K, Zou Q, Li L, Cao B*, Wang C.Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respi Viruses. 2017,11(4):345-354.SCI
30. Li H#, Cao B*.Pandemic and Avian Influenza A Viruses in Humans: Epidemiology, Virology, Clinical Characteristics, and Treatment Strategy. Clin Chest Med. 2017,38(1):59-70.SCI
31. Guo L#, Li G, Wang J, Zhao X, Wang S, Zhai L, Jia H, Cao B*.. Suspicious outbreak of ventilator-associated pneumonia caused by Burkholderia cepacia in a surgical intensive care unit. Am J Infect Control. 2017,45(6):660-666.SCI
32. Yin YD#, Wang R, Zhuo C, Wang H, Wang MG, Xie CM, She DY, Yuan X, Wang RT, Cao B*, Liu YN*.Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study[J]. J Thorac Dis. 2017,9(10):3774-3781.SCI
33. Xue C#, Wen M#, Bao L#, Li H, Li F, Liu M, Lv Q, An Y, Zhang X*, Cao B*.Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A. Front Immunol. 2017,8:1054.SCI
34. Shi SJ#, Li H, Liu M, Liu YM, Zhou F, Liu B, Qu JX, Cao B*.Mortality prediction to hospitalized patients with influenza pneumonia: PO 2 /FiO 2 combined lymphocyte count is the answer. Clin Respir J. 2017,11(3):352-360.SCI
35. Hu Y.F., Zhang Y., Ren X.W., Liu Y.M., Xiao Y., Li L., Yang F., Su H.X., Liu F., Liu HY.*, Cao B.*, Jin Q*..A case report demonstrating the utility of next generation sequencing in analyzing serial samples from the lung following an infection with influenza A (H7N9) virus. J Clin Virol. 2016,76(-):45-50.SCI
36. Cao B.#*, Gao H.N.#, Zhou B.P.#, Deng X.L.#, Hu C.P.#, Deng C.S., Lu H.Z., Li Y.P., Gan J.H., Liu J.Y., Li H., Zhang Y., Yang Y.D., Fang Q., Shen Y.Z., Gu Q., Zhou X.M., Zhao W., Pu Z.H., Chen L., Sun B.X., Liu X., Hamilton C.D., Li L.J.*.Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. Crit Care Med. 2016,44(6):e318-28.SCI
37. Shi S.J.#, Li H., Liu M., Liu Y.M., Zhou F., Liu B., Qu J.X., Cao B.*.Mortality prediction to hospitalized patients with influenza pneumonia: PO2/FiO2combined lymphocyte count is the answer. Clin Respir J. 2015,11 (3):352-360 .SCI
38. Hu Y.#, Ren X.#, Liu Y.#, Yang F., Liu H., Cao B.*, Jin Q.*.Serial high-resolution analysis of blood virome and host cytokines expression profile of a patient with fatal H7N9 infection by massively parallel RNA sequencing . Clin Microbiol Infect. 2015,21（7）:e1-4.SCI
39. Qu J.X.#, Gu L.#, Pu Z.H., Yu X.M., Liu Y.M., Li R., Wang Y.M., Cao B.*, Wang C..Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity . BMC Infect Dis. 2015,15(2):89.SCI
40. Cao B.#*, Qu J.X#., Yin Y.D.#, Eldere J.V.#.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.. Clin Respir J. 2015, 11 (4):419-429.SCI
41. Guo J.#, Huan F.#, Liu J.#, Chen Y.#, Wang W.#, Cao B.#, Zou Z., Liu S., Pan J., Bao C., Zeng M., Xiao H., Gao H., Yang S., Zhao Y., Liu Q., Zhou H., Zhu J., Liu X., Liang W., Yang Y., Zheng S., Yang J., Diao H., Su K., Shao L., Cao H., Wu Y., Zhao M., Tan S., Wang J.,Gao F.G.*, Li L.J.*, Jang C.Y.*.The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes. Sci Rep. 2015,5(-):e10942.SCI
42. Liu Y. M., Li B. B., Zhang Y. Y., Zhang W., Shen H., Li H., Cao B.*.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother. 2014,58(9):5379-5385.SCI
43. Liu B., Zhang X., Deng W., Liu J., Li H., Wen M., Bao L., Qu J., Liu Y., Li F., An Y., Qin C., Cao B.*, Wang C.*.Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-gamma. Cell Death Dis. 2014,5(-):e1440.SCI
44. Cao B.#, Huang G. H.#, Pu Z. H., Qu J. X., Yu X. M., Zhu Z., Dong J. P., Gao Y., Zhang Y. X., Li X. H., Liu J. H., Wang H., Xu Q., Li H., Xu W., Wang C.*.Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014,145(1):79-86.SCI
45. Wang C.#, Yu H.#, Horby P. W.#, Cao B.#, Wu P., Yang S., Gao H., Li H., Tsang T. K., Liao Q., Gao Z., Ip D. K., Jia H., Jiang H., Liu B., Ni M. Y., Dai X., Liu F., Van Kinh N., Liem N. T., Hien T. T., Li Y., Yang J., Wu J. T., Zheng Y., Leung G. M., Farrar J. J., Cowling B. J., Uyeki T. M., Li L..Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Clin Infect Dis. 2014,58(8):1095-1103.SCI
46. Cao B.*.What clinicians should know to fight against the novel avian-origin influenza A (H7N9) virus? . Chin Med J . 2013,126 (12):2205-2206.SCI
47. Cao B. Frederick G.Therapy of H7N9 pneumonia: current perspectives. Anti Infect. Ther. 2013,11(11):1123–1126.SCI
48. Qu J., Gu L., Wu J., Dong J., Pu Z., Gao Y., Hu M., Zhang Y., Gao F., Cao B.*, Wang C..Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infectious Diseases . 2013,13(1):172.SCI
49. Zeng X. C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S., Cao B.*, Cao H.*.Three new antimicrobial peptides from the scorpion Pandinus imperator. Peptides . 2013,45(-):28-34.SCI
50. Li F., Wu L., Cao B.*, Zhang Y., Li X., Liu Y. .Surveillance of the Prevalence, Antibiotic Susceptibility, and Genotypic Characterization of Invasive Candidiasis in a Teaching Hospital in China between 2006 to 2011. BMC Infectious Diseases . 2013,13(1):353.SCI
51. Gao H. N.#, Lu H. Z.#, Cao B.#, Du B.#, Shang H.#, Gan J. H., Lu S. H., Yang Y. D., Fang Q., Shen Y. Z., Xi X. M., Gu Q., Zhou X. M., Qu H. P., Yan Z., Li F. M., Zhao W., Gao Z. C., Wang G. F., Ruan L. X., Wang W. H., Ye J., Cao H. F., Li X. W., Zhang W. H., Fang X. C., He J., Liang W. F..Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med . 2013,368(24):2277-85.SCI
52. Gao R.#, Cao B.#, Hu Y., Feng Z., Wang D., Hu W., Chen J., Jie Z., Qiu H., Xu K., Xu X., Shen Y., He Z., Gu Y., Zhang Z., Yang Y., Zhao X., Zhou L., Li X., Zou S., Zhang Y., Li X., Yang L., Guo J., Dong J., Li Q., Dong L., Zhu Y., Bai T., Wang S., Hao P., Yang W., Zhan.Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med . 2013,368(20):1888-97.SCI
53. Ip D. K., Liao Q., Wu P., Gao Z., Cao B., Feng L., Xu X., Jiang H., Li M., Bao J., Zheng J., Zhang Q., Chang Z., Li Y., Yu J., Liu F., Ni M. Y., Wu J. T., Cowling B. J., Yang W., Leung G. M., Yu H..Detection of mild to moderate influenza A/H7N9 infection by China’s national sentinel surveillance system for influenza-like illness: case series. BMJ. 2013,346(-):f3693.SCI
54. Yin Y. D., Zhao F., Ren L. L., Song S. F., Liu Y. M., Zhang J. Z., Cao B.*.Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia. Respirology. 2012,17(7):1131-1136.SCI
55. Liu Y., Cao B.*, Gu L., Liu K., Feng Z..Successful control of vancomycin-resistant Enterococcus faecium nosocomial outbreak in a teaching hospital in China. Am J Infect Control. 2012,40(6):568-571.SCI
56. Gu L., Liu Z., Li X., Qu J., Guan W., Liu Y., Song S., Yu X., Cao B.*.Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing.. Journal of Clinical Virology. 2012,54(4):295-301.SCI
57. Wang C.*, Cao B.*, Liu Q. Q., Zou Z. Q., Liang Z. A., Gu L., Dong J. P., Liang L. R., Li X. W., Hu K., He X. S., Sun Y. H., An Y., Yang T., Cao Z. X., Guo Y. M., Wen X. M., Wang Y. G., Liu Y. L., Jiang L. D. .Oseltamivir vs. the Chinese Traditional Therapy Maxingshigan/Yinqiaosan in the Treatment of H1N1 Influenza: A Randomized Trial . Ann Intern Med. 2011,155(4):217-25.SCI
58. Bai L.#, Gu L.#, Cao B.#, Zhai X. L., Lu M., Lu Y., Liang L. R., Zhang L., Gao Z. F., Huang K. W., Liu Y. M., Song S. F., Wu L., Yin Y. D., Wang C. .Clinical Features of Pneumonia Caused by 2009 Influenza A(H1N1) Virus in Beijing, China. Chest. 2011,139（5）:1156-64.SCI
59. Cao B., Ren L. L., Zhao F., Gonzalez R., Song S. F., Bai L., Yin Y. D., Zhang Y. Y., Liu Y. M., Guo P., Zhang J. Z., Wang J. W., Wang C..Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients. Eur J Clin Microbiol Infect Dis. 2010,29(11):1443-1448.SCI
60. Cao B., Zhao C. J., Yin Y. D., Zhao F., Song S. F., Bai L., Zhang J. Z., Liu Y. M., Zhang Y. Y., Wang H., Wang C..High Prevalence of Macrolide Resistance in Mycoplasma pneumoniae Isolates from Adult and Adolescent Patients with Rrespiratory Tract Infections. Clin Infect Dis. 2010,51(2):189-194.SCI
61. Gu Li#, Cao Bin#, Liu Ying mei, Guo Ping, Song Shufan,Li Ran, Dai Huaping, Wang Chen*.A new Tn1546 type of Van B faecium isolates in mainland China. Diagn Microbiol Infect Dis. 2009,63:70-75.SCI
62. Cao B.#, Li X. W.#, Mao Y.#, Wang J.#, Lu H. Z., Chen Y. S., Liang Z. A., Liang L., Zhang S. J., Zhang B., Gu L., Lu L. H., Wang D. Y., Wang C..Clinical features of the initial influenza A H1N1 2009 cases in China. N Engl J Med. 2009,61(26）:2507-17.SCI
63. Cao B., Xingwang L., Yuelong S., Nan J., Shijun C., Xiayuan X., Chen W. .Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus, People’s Republic of China. Emerg Infect Dis. 2009,15(9):1418-1422.SCI
64. Wang Zhen, Cao Bin*, LIU Ying-mei , GU Li , WANG Chen*. Investigation of the prevalence that patients co-colonized or infected with Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: A hospital-based study. Chin Med J. 2009,122 (11):1283-1288.SCI
65. Cao B., Liu Y., Song S., Li R., Wang H., Wang C. .First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China. Int J Antimicrob Agents. 2008,32(3):279-281.SCI
66. Cao Bin, Wanghui, Zhu Renyuan, Ning Yongzhong, Xie Xiuli, Xu Yingchun, ZHu Yuanjue,Chenminjun*,.Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli. DIAGN MICR INFEC DIS. 2006,56(4):351-7.SCI
67. Bin Cao*, Hui Wang, Peng Wang, Mengtao Li, and Yuanjue Zhu.Clinical parameters and outcomes of Pneumocystis Jiroveci Pneumonia in non-HIV/AIDS patients. Chi Med J. 2006, 119 (3):234－237.SCI
主编或副主编的著作/译著
1. 《新型冠状病毒肺炎临床实用手册》,主编,中国协和医科大学出版社,202003
2. 《新冠肺炎防治精要》,主编,上海交通大学出版社,2020
3. 《临床微生物学手册》,副主译,中华医学电子音像出版社,201706
4. 《临床微生物学检验》,副主编,人民卫生出版社,201506
5. 《感染性疾病－基于临床病例的诊治析评》,主编,人民卫生出版社,200907
6. 《重症急性呼吸综合征（SARS）诊治》,副主编,人民卫生出版社,200306
重要奖项
1. 以防控人感染H7N9禽流感为代表的新发传染病防治体系重大创新和技术突破 国家科学技术进步奖 特等奖 201712
2. 人感染新型H7N9禽流感病毒的发现及其病原学研究 中华预防医学会科学技术奖 一等奖 201601
3. 急性呼吸道感染及新发呼吸道传染病 奖励计划 201501
4. 急性呼吸道感染及新发呼吸道传染病 树兰医学青年奖 —— 201412
5. 急性呼吸道感染及新发呼吸道传染病 全国优秀科技工作者 —— 201412
6. 急性呼吸道感染和新发呼吸道传染病 吴阶平－保罗.杨森医学药学奖 - 201411
7. 甲型H1N1流感应用和基础研究 第十四届北京茅以升青年科技奖 —— 201205
8. 甲型H1N1流感临床和应用基础研究 北京市科技进步奖 一等奖 201012